CureVac N.V.
CVAC · NASDAQ
Bulios Fair Price
$5.29
14.1% upside
Trenutna cena
$4.64
Po podatkih Bulios Fair Price je delnica CVAC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
CureVac N.V. (CVAC) is a biotechnology company focused on developing innovative drugs and therapies based on messenger RNA (mRNA) technology. The company is dedicated to researching and developing medicines and vaccines targeting various diseases, including infectious diseases, cancer, and other health conditions. CureVac plays a pivotal role in the field of mRNA technology development and its potential in disease treatment and prevention. Their mRNA vaccine against infectious diseases gained significant attention during the COVID-19 pandemic. Shares of CureVac N.V. (CVAC) can be an interesting choice for investors tracking the biotechnology sector and innovations in the field of drugs and vaccines.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander Zehnder
Employees
825
Headquarters
Tübingen